Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29197686)

  • 1. The impact of screening on cancer incidence and mortality in Missouri, USA, 2004-2013.
    Yoshida Y; Schmaltz CL; Jackson-Thompson J; Simoes EJ
    Public Health; 2018 Jan; 154():51-58. PubMed ID: 29197686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer screening estimates for U.S. metropolitan areas.
    Nelson DE; Bolen J; Marcus S; Wells HE; Meissner H
    Am J Prev Med; 2003 May; 24(4):301-9. PubMed ID: 12726867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol consumption and rates of cancer screening: Is cancer risk overestimated?
    Mu L; Mukamal KJ
    Cancer Causes Control; 2016 Feb; 27(2):281-9. PubMed ID: 26590914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
    Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
    Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. County-Level Social Vulnerability and Breast, Cervical, and Colorectal Cancer Screening Rates in the US, 2018.
    Bauer C; Zhang K; Xiao Q; Lu J; Hong YR; Suk R
    JAMA Netw Open; 2022 Sep; 5(9):e2233429. PubMed ID: 36166230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Cancer Screening, Incidence, and Mortality Across US Counties.
    Harding C; Pompei F; Burmistrov D; Welch HG; Abebe R; Wilson R
    JAMA Intern Med; 2015 Sep; 175(9):1483-9. PubMed ID: 26147578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
    Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
    Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonbreast cancer incidence, treatment received and outcomes: Are there differences in breast screening attendees versus nonattendees?
    Walpole E; Dunn N; Youl P; Harden H; Furnival C; Moore J; Taylor K; Evans E; Philpot S
    Int J Cancer; 2020 Aug; 147(3):856-865. PubMed ID: 31808149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in breast cancer screening in Missouri from 1987 to 1995, and predictions for the years 2000 and 2010.
    Sarr M; Simoes EJ; Murayi T; Figgs LT; Brownson RC
    Mo Med; 1998 Dec; 95(12):663-9. PubMed ID: 9863343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Mammography, Pap Smear, and Colorectal Cancer Screening Services Among Women Aged 45 and Over.
    Gorina Y; Elgaddal N
    Natl Health Stat Report; 2021 Jun; (157):1-18. PubMed ID: 34181518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Cancer Mortality-to-Incidence Ratios with Increased Accessibility of Federally Qualified Health Centers.
    Adams SA; Choi SK; Khang L; A Campbell D; Friedman DB; Eberth JM; Glasgow RE; Tucker-Seeley R; Xirasagar S; Yip MP; Young VM; Hébert JR
    J Community Health; 2015 Aug; 40(4):633-41. PubMed ID: 25634545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer test use--Maryland, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and cancer screening rates among Appalachian and non-Appalachian residents of Kentucky.
    Fleming ST; Love MM; Bennett K
    J Am Board Fam Med; 2011; 24(6):682-92. PubMed ID: 22086811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of breast and cervical cancer screening in a Spanish metropolitan area.
    López-de-Andrés A; Martin-Lopez R; Hernández-Barrera V; Carrasco-Garrido P; Gil-de-Miguel A; Esteban y Peña MM; Jiménez-García R
    J Womens Health (Larchmt); 2010 Sep; 19(9):1675-81. PubMed ID: 20799924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Cancer Screening in the Era of the Affordable Care Act.
    Richman I; Asch SM; Bhattacharya J; Owens DK
    J Gen Intern Med; 2016 Mar; 31(3):315-20. PubMed ID: 26349953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.